Publications by authors named "F J Adrian"

Claim this Profile
P
Population pharmacokinetics and pharmacodynamics of HFB30132A, a monoclonal antibody against SARS-CoV-2, in healthy Chinese and US subjects.
Yuancheng Chen, Size Li, William Hedrich, Xiaojie Wu, Shanshan Li, Francisco Adrian

Int J Antimicrob Agents· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide.
H Jiang, C Acharya, G An, M Zhong, X Feng, F Adrian

Leukemia· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, pharmacokinetics, and immunogenicity of an anti-SARS-CoV-2 monoclonal antibody HFB30132A after single dose intravenous administration in healthy Chinese subjects: a phase 1, randomized, double-blind, placebo-controlled study.
Shanshan Li, Xiaojie Wu, Nanyang Li, Guoying Cao, Jingjing Wang, Francisco Adrian

Front Pharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD38 monoclonal antibody interference with blood compatibility testing: Differentiating isatuximab and daratumumab via functional epitope mapping.
Btissam Chami, Makoto Okuda, Morvarid Moayeri, France Pirenne, Yoko Hidaka, Francisco Adrian

Transfusion· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Preclinical Activity of Isatuximab in Patients with Acute Lymphoblastic Leukemia.
Anlai Wang, Zhili Song, Gang Zheng, Celine Nicolazzi, Jonathan R Fromm, Francisco J Adrian

Mol Cancer Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis